Icon

PLAQUENIL (nda009768)- (200MG)

HYDROXYCHLOROQUINE SULFATE CONCORDIA
200MG
No No
Expired Expired
None None
None No
PLAQUENIL is an antimalarial and antirheumatic indicated for the: • Treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax in adult and pediatric patients. • Prophylaxis of malaria in geographic areas where chloroquine resistance is not reported in adult and pediatric patients. • Treatment of rheumatoid arthritis in adults. • Treatment of systemic lupus erythematosus in adults. • Treatment of chronic discoid lupus erythematosus in adults.
13 0 12
Total Other Developers 16
Drugs with Suitability Yes
200MG ** ** - - 7
NDA Sales Available Total Generic Sales Available
No 11
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** *** *** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** **** **** *** **** ************ ******* *********** **** **. **, ** *** ***, ******** ********** ******, *******, ********, *.*. ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** **** **** *** **** ************ ******* *********** *, ****** ****, ***, ******, *********, ****, ****** ******* ******, ***** (***) ***
****** **** **** *** ******** **** *******, ***. *********** * ******* *****, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ********* *** ********* ********** **** ********** ****** **************** *********** ***** ***** *. **., ************, - *****, ******* (***) ***
****** ***** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** **** ******* *********** **** **. **, ** & **, ******* ****** ***** *********** *******, ******** ******, **********, ****** ******* ******, ***** (***) ***
****** ****** ****** **** ******* *** *********** **** **. **, ** & **, ******* ****** ***** *********** *******, ******** ******, **********, ****** ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.